Proton Therapy Market (By Type, Product Type, Setup Type, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032

The global proton therapy market was valued at USD 1.65 billion in 2025, and is projected to reach USD 3.12 billion by 2032, growing steadily during the forecast period.

Proton therapy is one of the most advanced and precise forms of radiation therapy used for cancer treatment. Unlike conventional radiation therapy, it delivers highly targeted radiation directly to the tumor while minimizing exposure to surrounding healthy tissues and vital organs. This precision enhances treatment effectiveness, reduces the risk of side effects, and improves patient outcomes. As a non-invasive treatment modality, proton therapy also helps patients maintain a better quality of life and return to normal daily activities more quickly. Additionally, its ability to safely deliver higher radiation doses to tumors makes it particularly effective for treating pediatric cancers and tumors located near critical structures.

The proton therapy market is experiencing robust growth, driven by the rising global incidence of cancer and the increasing demand for highly precise, minimally invasive treatment options. Growing awareness among healthcare providers and patients regarding the clinical advantages of proton therapy, coupled with technological advancements in compact and cost-efficient proton therapy systems, is accelerating market adoption. Furthermore, increasing investments by hospitals and cancer treatment centers, expanding reimbursement support in several countries, and favorable government initiatives aimed at improving access to advanced oncology care are contributing significantly to market expansion. The increasing focus on personalized cancer treatment and continuous research to broaden the clinical applications of proton therapy are expected to further support market growth over the coming years.

Recent Developments

• In March 2025, Apollo Hospitals partnered with Ion Beam Applications (IBA) to bring Proteus One Proton Beam Therapy to India, revolutionizing cancer care with advanced technology. The introduction of the Proteus One system, featuring the DynamicARC beam delivery technology, is expected to revolutionize cancer treatment by providing more precise, personalized, and effective therapies.
• In December 2024, Mevion Medical Systems received approval from China’s NMPA, making it the first compact, single-room proton therapy system available in China. Its smaller footprint and integrated design reduce costs and expand access to advanced cancer treatment.
• In September 2024, BayCare Cancer Institute began construction on its first proton therapy center at St. Joseph's Hospital in Tampa Bay, Florida. The facility will utilize Mevion Medical Systems’ compact MEVION S250-FIT proton therapy system. This initiative marks BayCare’s entry into next-generation radiation oncology and is expected to expand access to advanced proton therapy treatments across the southeastern United States.
• In January 2024, Varian Medical Systems announced a collaboration with Elekta AB to develop and commercialize proton therapy treatment planning software. The partnership combines the expertise of both companies to create a more comprehensive and user-friendly solution for clinicians. This collaboration has the potential to accelerate the adoption of proton therapy by simplifying clinical workflows and improving integration into existing treatment processes.

By Type - Global Proton Therapy Market - Key Takeaways

• By type, the rotating proton therapy systems dominated the market in 2025, owing to their superior treatment flexibility, precise beam delivery from multiple angles, and ability to treat a wide range of complex tumor types. These systems enable clinicians to optimize radiation dose distribution while minimizing exposure to surrounding healthy tissues, making them the preferred choice for leading cancer treatment centers.
• The non-rotating proton therapy systems are expected to witness steady growth over the forecast period, driven by their lower installation and maintenance costs compared to rotating systems. These systems offer a more compact design, reduced infrastructure requirements, and improved affordability, making them an attractive option for hospitals and cancer centers with budget or space constraints.

By Product Type - Global Proton Therapy Market - Key Takeaways

• By product type, the Accelerators segment accounted for largest share of the global proton therapy market in 2025. Accelerators, including synchrotrons, synchrocyclotrons, cyclotrons, and linear accelerators (linacs), are the core components of proton therapy systems, generating and accelerating proton beams to the high energy levels required for precise cancer treatment. Their ability to deliver accurate and controlled proton beams enables effective tumor targeting while minimizing radiation exposure to surrounding healthy tissues. Ongoing technological advancements are focused on developing more compact, cost-effective, and energy-efficient accelerator systems, reducing facility size and installation costs while expanding accessibility to proton therapy worldwide.
• The Beam Delivery System segment is projected to register the fastest growth during the forecast period, driven by continuous advancements in beam delivery technologies and the increasing demand for highly precise and efficient cancer treatment. Beam delivery systems, including pencil beam scanning (PBS) and passive scattering technologies, play a critical role in accurately directing proton beams to tumors while minimizing radiation exposure to surrounding healthy tissues. Growing adoption of pencil beam scanning, owing to its superior dose conformity and ability to treat complex and irregularly shaped tumors, is a key factor supporting segment growth.
• The Beam Transport System is expected to witness significant growth during the forecast period, driven by the increasing deployment of advanced proton therapy facilities and continuous technological advancements in proton beam delivery infrastructure. Beam transport systems are a critical component of proton therapy, responsible for guiding and controlling proton beams from the accelerator to the treatment room with high precision while maintaining beam quality and energy.
• The Nozzle & Image Viewers segment is expected to experience steady growth during the forecast period, driven by the increasing demand for enhanced treatment accuracy and real-time imaging in proton therapy. The treatment nozzle is a critical component that shapes, modulates, and precisely delivers the proton beam to the target tumor, while image viewers facilitate accurate patient positioning, treatment planning, and real-time verification during therapy.

By Setup Type - Global Proton Therapy Market - Key Takeaways

• Based on setup type, the Multi-Room Systems accounted for largest share of the global proton therapy market in 2025, driven by its high patient throughput, operational efficiency, and widespread adoption by large cancer treatment centers. Multi-room proton therapy systems utilize a centralized accelerator to generate proton beams that can be directed to multiple treatment rooms, enabling simultaneous or sequential treatment of several patients from a single system. This shared infrastructure improves resource utilization, reduces per-patient treatment costs, and increases the overall capacity of proton therapy facilities.
• The Single-Room Systems are expected to register significant growth during the forecast period, driven by the rising incidence of cancer, increasing demand for cost-effective proton therapy solutions, and advancements in compact system design. Compared with multi-room facilities, single-room systems require lower capital investment, reduced maintenance costs, and less installation space, making them an attractive option for hospitals and cancer centers with limited infrastructure or budgets.

By Application - Global Proton Therapy Market - Key Takeaways

• The Lung Cancer segment accounted for the largest share of the global proton therapy market in 2025, and is expected to maintain its leading position over the forecast period. The growing prevalence of lung cancer worldwide, coupled with the increasing demand for highly precise radiation therapy, is a key factor driving segment growth. Because the lungs are located close to vital structures such as the heart, spinal cord, and esophagus, proton therapy offers a significant clinical advantage over conventional radiation therapy by limiting radiation doses to these sensitive organs. This precision reduces the risk of complications and improves treatment outcomes, particularly for patients with locally advanced or recurrent disease.
• The Brain Tumors segment accounted for a significant share of the global proton therapy market in 2025, driven by the increasing incidence of primary and metastatic brain tumors and the growing demand for highly precise radiation treatment. Proton therapy offers superior dose conformity, enabling clinicians to deliver high radiation doses directly to the tumor while minimizing exposure to surrounding healthy brain tissue and critical neurological structures. This precision helps reduce treatment-related side effects, including neurocognitive decline, hormonal dysfunction, and radiation-induced damage, making it particularly beneficial for pediatric patients and individuals with tumors located near sensitive areas of the brain.
• The Sarcomas application segment is expected to witness significant growth in the proton therapy market during the forecast period, driven by the clinical benefits of proton therapy in treating complex and challenging tumors. Sarcomas often develop in locations close to critical organs, bones, and sensitive tissues, making precise radiation delivery essential for effective treatment while minimizing damage to surrounding healthy structures.
• The Pediatric Cancer application segment is driven by the significant clinical advantages of proton therapy in treating pediatric malignancies, where minimizing radiation exposure to developing organs and healthy tissues is a major priority. Proton therapy enables highly precise radiation delivery to tumors while reducing radiation doses to surrounding normal tissues, helping lower the risk of long-term treatment-related complications such as cognitive impairment, hormonal disorders, and growth-related effects. The technology is particularly beneficial for pediatric patients due to their developing bodies, longer life expectancy, and increased sensitivity to radiation-induced damage, making proton therapy a preferred treatment option for reducing late adverse effects and improving long-term quality of life.

By End User - Global Proton Therapy Market - Key Takeaways

• The Hospitals segment accounted for largest share of the global proton therapy market in 2025, driven by the increasing demand for advanced cancer treatment options and the expanding role of hospitals in the development and adoption of proton therapy. Hospitals serve as key centers for proton therapy implementation by establishing new treatment facilities, supporting clinical research, collaborating on technological advancements, and improving patient access to advanced radiation therapy. Additionally, hospitals are increasingly investing in multidisciplinary oncology teams, specialized training programs, and safety protocols to ensure the effective delivery of proton therapy.
• The Proton Therapy Centers segment is expected to experience significant growth during the forecast period, driven by the increasing adoption of advanced proton therapy techniques and the rising number of dedicated cancer treatment facilities worldwide. Specialty proton therapy centers play a crucial role in advancing the use of technologies such as intensity-modulated proton therapy (IMPT) and pencil beam scanning, enabling more precise radiation delivery, improved tumor targeting, and reduced exposure to surrounding healthy tissues. These centers focus on specialized expertise, clinical research, and multidisciplinary approaches to enhance treatment outcomes and minimize side effects, particularly for complex cancer cases.

By Region - Global Proton Therapy Market - Key Takeaways

• Based on region, North America accounted for largest share of the global proton therapy market in 2025, supported by the presence of advanced healthcare infrastructure, a growing number of proton therapy facilities, and increasing demand for precision cancer treatment solutions. The rising prevalence of chronic diseases, increasing cancer burden, and changing lifestyle and dietary patterns are contributing to the growing adoption of proton therapy across the region. Additionally, the presence of leading proton therapy technology providers and increasing focus on advanced cancer care are expected to maintain the regions’ dominance in the proton therapy market over the forecast period.
• The Europe proton therapy market is expected to witness significant growth during the forecast period, driven by the rising prevalence of cancer, increasing demand for advanced radiation therapy solutions, and expanding access to precision oncology treatments. The market growth in Europe is further supported by the expansion of proton therapy centers, increasing investments in advanced healthcare infrastructure, and collaborations between hospitals, research institutions, and technology providers.
• The Asia Pacific proton therapy market is expected to witness substantial growth during the forecast period, driven by the rising cancer burden, increasing healthcare investments, and expanding adoption of advanced radiation therapy technologies across the region. Countries such as Japan, China, and India are emerging as key contributors to regional market expansion due to improvements in healthcare infrastructure, increasing access to advanced oncology treatments, and growing demand for precision cancer care. Japan has been at the forefront of proton therapy adoption due to its long-standing expertise, advanced medical infrastructure, and strong government support for innovative cancer treatment technologies. China is witnessing rapid growth in the proton therapy market due to its increasing cancer patient population, rising healthcare expenditure, and government initiatives focused on improving cancer care capabilities. The expansion of specialized oncology centers, development of domestic healthcare infrastructure, and growing investments in advanced radiation therapy technologies are supporting the adoption of proton therapy across the country.

The report provides a comprehensive analysis of the Global Proton Therapy Market.

This report has been analyzed from 12 View Points:

1) Global - Proton Therapy Market and Forecast (2021 - 2032)
2) Global - Proton Therapy Market Share and Forecast (2021 - 2032)
3) By Type - Global Proton Therapy Market and Forecast (2021 - 2032)
4) By Product Type - Global Proton Therapy Market and Forecast (2021 - 2032)
5) By Setup Type - Global Proton Therapy Market and Forecast (2021 - 2032)
6) By Application - Global Proton Therapy Market and Forecast (2021 - 2032)
7) By End User - Global Proton Therapy Market and Forecast (2021 - 2032)
8) By Region - Global Proton Therapy Market and Forecast (2021 - 2032)
9) Global Proton Therapy Market - Recent Developments
10) Global Proton Therapy Market - Trends
11) Global Proton Therapy Market - Key Company Profiles
12) Global Proton Therapy - Market Dynamics

By Type - Global Proton Therapy Market and Forecast

• Rotating Proton Therapy Systems
• Non-Rotating Proton Therapy Systems

By Product Type - Global Proton Therapy Market and Forecast

• Accelerator
• Beam Delivery System
• Beam Transport System
• Nozzle & Image Viewers
• Patient Positioning System

By Setup Type - Global Proton Therapy Market and Forecast

• Multi-Room Systems
• Single-Room Systems

By Application - Global Proton Therapy Market and Forecast

• Lung Cancer
• Brain Cancer
• Sarcomas
• Pediatric Cancer
• Gastro-Intestinal Cancer
• Prostate Cancer
• Head & Neck Cancer

By End User - Global Proton Therapy Market and Forecast

• Hospitals
• Proton Therapy Centers
• Others

By Region - Proton Therapy Market & Forecast

1. North America

• United States
• Canada

2. Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Netherlands

3. Asia Pacific

• Japan
• China
• India
• Australia
• South Korea

4. Latin America

• Brazil
• Mexico
• Argentina

5. Middle East & Africa

• South Africa
• Saudi Arabia
• UAE

Global Proton Therapy Market - Key Company Profiles

1. Ion Beam Applications SA
2. Hitachi, Ltd.
3. Sumitomo Heavy Industries, Ltd
4. Mitsubishi Electric Corporation
5. Siemens Healthineers AG
6. Mevion Medical Systems
7. Optivus Proton Therapy
8. Advanced Oncotherapy plc
9. ProTom International
10. Provision Healthcare